BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25022264)

  • 1. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
    Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
    Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
    Li J; Shan Y; Fan S; Liu X
    Mycopathologia; 2014 Oct; 178(3-4):279-83. PubMed ID: 25118875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida nivariensis in comparison to different phenotypes of Candida glabrata.
    Swoboda-Kopeć E; Sikora M; Golas M; Piskorska K; Gozdowski D; Netsvyetayeva I
    Mycoses; 2014 Dec; 57(12):747-53. PubMed ID: 25267284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
    Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
    J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
    Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
    J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
    Asadzadeh M; Alanazi AF; Ahmad S; Al-Sweih N; Khan Z
    PLoS One; 2019; 14(10):e0223920. PubMed ID: 31618264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
    Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
    J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
    Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
    Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA.
    Mirhendi H; Bruun B; Schønheyder HC; Christensen JJ; Fuursted K; Gahrn-Hansen B; Johansen HK; Nielsen L; Knudsen JD; Arendrup MC
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1409-16. PubMed ID: 21607825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR.
    Enache-Angoulvant A; Guitard J; Grenouillet F; Martin T; Durrens P; Fairhead C; Hennequin C
    J Clin Microbiol; 2011 Sep; 49(9):3375-9. PubMed ID: 21752976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis.
    Wahyuningsih R; SahBandar IN; Theelen B; Hagen F; Poot G; Meis JF; Rozalyani A; Sjam R; Widodo D; Djauzi S; Boekhout T
    J Clin Microbiol; 2008 Jan; 46(1):388-91. PubMed ID: 18003796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
    Sharma C; Wankhede S; Muralidhar S; Prakash A; Singh PK; Kathuria S; Kumar DA; Khan N; Randhawa HS; Meis JF; Chowdhary A
    Diagn Microbiol Infect Dis; 2013 May; 76(1):46-50. PubMed ID: 23537782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.
    Cuenca-Estrella M; Gomez-Lopez A; Isla G; Rodriguez D; Almirante B; Pahissa A; Rodriguez-Tudela JL;
    Med Mycol; 2011 Jul; 49(5):525-9. PubMed ID: 21198347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.
    Lockhart SR; Messer SA; Gherna M; Bishop JA; Merz WG; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2009 Apr; 47(4):1216-7. PubMed ID: 19193845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China.
    Shi XY; Yang YP; Zhang Y; Li W; Wang JD; Huang WM; Fan YM
    J Med Microbiol; 2015 Apr; 64(Pt 4):390-393. PubMed ID: 25596116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida bracarensis bloodstream infection in an immunocompromised patient.
    Warren TA; McTaggart L; Richardson SE; Zhang SX
    J Clin Microbiol; 2010 Dec; 48(12):4677-9. PubMed ID: 20881164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.
    Eddouzi J; Hofstetter V; Groenewald M; Manai M; Sanglard D
    J Clin Microbiol; 2013 Jan; 51(1):31-9. PubMed ID: 23077122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isolation of Candida rugosa and Candida mesorugosa from clinical samples in Ghana.
    Adjapong G; Bartlett M; Hale M; Garrill A
    Med Mycol; 2016 Mar; 54(3):322-6. PubMed ID: 26705831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.